| 臺大學術典藏 |
2020-03-05T07:31:49Z |
TERT promoter mutation is uncommon in acral lentiginous melanoma
|
Kuo K.-T.; Chu C.-Y.; Jeng Y.-M.; JIA-HUEI TSAI; Liau J.-Y.; Liau J.-Y.;Jia-Huei Tsai;Jeng Y.-M.;Chu C.-Y.;Kuo K.-T.;Liang C.-W.; Liang C.-W. |
| 臺大學術典藏 |
2020-03-05T07:31:49Z |
Frequent activating HRAS mutations in trichilemmoma
|
Jia-Huei Tsai;Huang W.-C.;Jhuang J.-Y.;Jeng Y.-M.;Cheng M.-L.;Chiu H.-Y.;Kuo K.-T.;Liau J.-Y.; JIA-HUEI TSAI; Huang W.-C.; Jhuang J.-Y.; Jeng Y.-M.; Cheng M.-L.; Chiu H.-Y.; Kuo K.-T.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T07:31:49Z |
GNAS Is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct
|
Jeng Y.-M.; Liau J.-Y.; Yuan R.-H.; Chen Y.-L.; JIA-HUEI TSAI |
| 臺大學術典藏 |
2020-03-05T07:31:49Z |
The presence of clusters of plasmacytoid dendritic cells is a helpful feature for differentiating lupus panniculitis from subcutaneous panniculitis-like T-cell lymphoma
|
Liau J.-Y.; Chuang S.-S.; Chu C.-Y.; Ku W.-H.; JIA-HUEI TSAI; Shih T.-F. |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis
|
JIA-HUEI TSAI; Liau J.-Y.; Lin Y.-L.; Lin L.-I.; Cheng Y.-C.; Cheng M.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Morphological subclassification of intrahepatic cholangiocarcinoma: Etiological, clinicopathological, and molecular features
|
Liau J.-Y.; JIA-HUEI TSAI; Yuan R.-H.; Chang C.-N.; Lee H.-J.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T07:31:47Z |
Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome
|
Liau J.-Y.;Jia-Huei Tsai;Jeng Y.-M.;Lee J.-C.;Hsu H.-H.;Yang C.-Y.; Liau J.-Y.; JIA-HUEI TSAI; Jeng Y.-M.; Lee J.-C.; Hsu H.-H.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-05T07:31:47Z |
Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas
|
Liau J.-Y.;Jia-Huei Tsai;Yang C.-Y.;Lee J.-C.;Liang C.-W.;Hsu H.-H.;Jeng Y.-M.; Liau J.-Y.; JIA-HUEI TSAI; Yang C.-Y.; Lee J.-C.; Liang C.-W.; Hsu H.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T07:31:46Z |
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
|
JIA-HUEI TSAI; Hsu H.-H.; Yang C.-Y.; Lee J.-C.;Jeng Y.-M.;Liau J.-Y.;Jia-Huei Tsai;Hsu H.-H.;Yang C.-Y.; Lee J.-C.; Jeng Y.-M.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T07:31:46Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Yeh K.-H.; Cheng A.-L.; Chang Y.-L.; Lin L.-I.; Tseng L.-H.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Hung J.-S. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
TERT promoter mutations in periocular carcinomas: Implications of ultraviolet light in pathogenesis
|
Lin S.-Y.;Liao S.-L.;Hong J.-B.;Chu C.-Y.;Sheen Y.-S.;Jhuang J.-Y.;Jia-Huei Tsai;Liau J.-Y.; Lin S.-Y.; Liao S.-L.; Hong J.-B.; Chu C.-Y.; Sheen Y.-S.; Jhuang J.-Y.; JIA-HUEI TSAI; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; JIA-HUEI TSAI; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy
|
JIA-HUEI TSAI; Liau J.-Y.; Yuan C.-T.; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Jia-Huei Tsai;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Jeng Y.-M.; JIA-HUEI TSAI; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
The diagnostic utility of PAX8 for neuroendocrine tumors: An immunohistochemical reappraisal
|
Liau J.-Y.; JIA-HUEI TSAI; Jeng Y.-M.; Kuo K.-T.; Huang H.-Y.; Liang C.-W.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-05T07:31:44Z |
Frequent PIK3CA activating mutations in nipple adenomas
|
Sheen Y.-S.; Liau J.-Y.;Lee Y.-H.;Jia-Huei Tsai;Yuan C.-T.;Chu C.-Y.;Hong J.-B.;Sheen Y.-S.; Liau J.-Y.; Lee Y.-H.; JIA-HUEI TSAI; Yuan C.-T.; Chu C.-Y.; Hong J.-B. |
| 臺大學術典藏 |
2020-03-05T07:31:44Z |
Frequent PIK3CA-activating mutations in hidradenoma papilliferums
|
Liau J.-Y.; Lan J.; Hong J.-B.; JIA-HUEI TSAI; Kuo K.-T.; Chu C.-Y.; Sheen Y.-S.; Huang W.-C. |
| 臺大學術典藏 |
2020-03-05T07:31:44Z |
Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions
|
JIA-HUEI TSAI; Cheng C.-H.; Chen C.-C.; Lin Y.-L.; Lin L.-I.; Chen M.-L.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T07:31:43Z |
NRASQ61R immunohistochemistry detects both NRASQ61R and KRASQ61R mutations in colorectal cancer
|
Liau J.-Y.; JIA-HUEI TSAI; Jhuang J.-Y.;Yuan C.-T.;Lin Y.-L.;Cheng M.-L.;Liau J.-Y.;Jia-Huei Tsai; Jhuang J.-Y.; Yuan C.-T.; Lin Y.-L.; Cheng M.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:42Z |
Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype
|
Huang W.-C.;Liau J.-Y.;Jeng Y.-M.;Liu K.-L.;Lin C.-N.;Song H.-L.;Jia-Huei Tsai; Huang W.-C.; Liau J.-Y.; Jeng Y.-M.; Liu K.-L.; Lin C.-N.; Song H.-L.; JIA-HUEI TSAI |
| 臺大學術典藏 |
2020-03-05T07:31:42Z |
GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma
|
Liau J.-Y.;Jia-Huei Tsai;Lan J.;Chen C.-C.;Wang Y.-H.;Lee J.-C.;Huang H.-Y.; Liau J.-Y.; JIA-HUEI TSAI; Lan J.; Chen C.-C.; Wang Y.-H.; Lee J.-C.; Huang H.-Y. |
| 臺大學術典藏 |
2020-03-05T07:31:42Z |
Clonal sequence tracking reveals TET2-mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus
|
Huang T.-C.; Chuang C.-C.; Chuang Y.-K.; JIA-HUEI TSAI; Liau J.-Y.; Lin C.-W.; Tang J.-L.; Yuan C.-T. |
| 臺大學術典藏 |
2020-03-05T07:31:42Z |
BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin
|
Liau J.-Y.;Jia-Huei Tsai;Huang W.-C.;Lan J.;Hong J.-B.;Yuan C.-T.; Liau J.-Y.; JIA-HUEI TSAI; Huang W.-C.; Lan J.; Hong J.-B.; Yuan C.-T. |
| 臺大學術典藏 |
2020-03-05T07:31:41Z |
Traditional Serrated Pathway-Associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations
|
Jia-Huei Tsai;Jeng Y.-M.;Yuan C.-T.;Lin Y.-L.;Cheng M.-L.;Liau J.-Y.; JIA-HUEI TSAI; Jeng Y.-M.; Yuan C.-T.; Lin Y.-L.; Cheng M.-L.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T07:31:41Z |
High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a histopathological and molecular study of 85 cases indicating GNA14 as the most commonly mutated gene in vascular neoplasms
|
Liau J.-Y.;Lee J.-C.;Jia-Huei Tsai;Chen C.-C.;Chung Y.-C.;Wang Y.-H.; Liau J.-Y.; Lee J.-C.; JIA-HUEI TSAI; Chen C.-C.; Chung Y.-C.; Wang Y.-H. |
| 臺大學術典藏 |
2020-03-05T07:31:40Z |
Thrombotic Hemangioma with Organizing/Anastomosing Features: Expanding the Spectrum of GNA -mutated Hemangiomas with a Predilection for the Skin of the Lower Abdominal Regions
|
Liau J.-Y.;Lee J.-C.;Jia-Huei Tsai;Chen C.-C.;Wang Y.-H.;Chung Y.-C.; Liau J.-Y.; Lee J.-C.; JIA-HUEI TSAI; Chen C.-C.; Wang Y.-H.; Chung Y.-C. |
| 臺大學術典藏 |
2020-03-05T06:38:59Z |
Dedifferentiated liposarcoma with homologous lipoblastic differentiation: Expanding the spectrum to include low-grade tumours
|
Wu C.-T.; Kuo K.-T.; Huang H.-Y.; Liang C.-W.; JEN-CHIEH LEE; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T06:38:58Z |
Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome
|
Yang C.-Y.; Hsu H.-H.; JEN-CHIEH LEE; Jeng Y.-M.; Tsai J.-H.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T06:38:58Z |
Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas
|
Liau J.-Y.; Tsai J.-H.; Yang C.-Y.; JEN-CHIEH LEE; Liang C.-W.; Hsu H.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:38:58Z |
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma
|
Yang C.-Y.; Liau J.-Y.; Huang W.-J.; Chang Y.-T.; Chang M.-C.; JEN-CHIEH LEE; Tsai J.-H.; Su Y.-N.; Hung C.-C.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:38:58Z |
Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis
|
JEN-CHIEH LEE; Wu J.-M.; Liau J.-Y.; Huang H.-Y.; Lo C.-Y.; Jan I.-S.; Hornick J.L.; Qian X. |
| 臺大學術典藏 |
2020-03-05T06:38:57Z |
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
|
JEN-CHIEH LEE; Jeng Y.-M.; Liau J.-Y.; Tsai J.-H.; Hsu H.-H.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-05T06:38:57Z |
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
|
Liau J.-Y.; JEN-CHIEH LEE; Tsai J.-H.; Yang C.-Y.; Liu T.-L.; Ke Z.-L.; Hsu H.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:38:55Z |
GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma
|
Huang H.-Y.; JEN-CHIEH LEE; Wang Y.-H.; Chen C.-C.; Lan J.; Tsai J.-H.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T06:38:53Z |
Thrombotic Hemangioma with Organizing/Anastomosing Features: Expanding the Spectrum of GNA -mutated Hemangiomas with a Predilection for the Skin of the Lower Abdominal Regions
|
Chung Y.-C.; Wang Y.-H.; Tsai J.-H.; Chen C.-C.; JEN-CHIEH LEE; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T05:51:19Z |
Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition
|
Wang C.-C.; Liau J.-Y.; Lu Y.-S.; Chen J.-W.; Yao Y.-T.; HUANG-CHUN LIEN |
| 臺大學術典藏 |
2020-03-03T03:36:40Z |
Clonal sequence tracking reveals TET2-mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus
|
Yuan C.-T.; Huang T.-C.; Chuang C.-C.; Chuang Y.-K.; Tsai J.-H.; Liau J.-Y.; CHUNG-WU LIN; Tang J.-L. |
| 臺大學術典藏 |
2020-02-25T05:15:28Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-25T05:15:26Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Liau J.-Y.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H. |
| 臺大學術典藏 |
2020-02-25T05:15:25Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-25T05:15:25Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-24T05:13:14Z |
Expansile kaposiform hemangioendothelioma deformed thoracic cage in an adult
|
Wu C.-H.; Tsai T.-M.; Liau J.-Y.; Chang Y.-L.; HONG-SHIEE LAI; Lee J.-M. |
| 臺大學術典藏 |
2020-02-24T02:29:11Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; BEEN-REN LIN; Cheng A.-L.; Yeh K.-H.; Chen K.-H.; Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Been-Ren Lin;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2020-02-20T02:57:00Z |
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma
|
CHING-YAO YANG; Liau J.-Y.; Huang W.-J.; Chang Y.-T.; Chang M.-C.; Lee J.-C.; Tsai J.-H.; Su Y.-N.; Hung C.-C.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-02-20T02:56:59Z |
Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome
|
Liau J.-Y.; Tsai J.-H.; Jeng Y.-M.; Lee J.-C.; Hsu H.-H.; CHING-YAO YANG |
| 臺大學術典藏 |
2020-02-20T02:56:59Z |
Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas
|
Liau J.-Y.; Tsai J.-H.; CHING-YAO YANG; Lee J.-C.; Liang C.-W.; Hsu H.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-02-20T02:56:57Z |
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
|
Liau J.-Y.; Lee J.-C.; Tsai J.-H.; CHING-YAO YANG; Liu T.-L.; Ke Z.-L.; Hsu H.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-02-20T02:56:57Z |
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
|
Lee J.-C.;Jeng Y.-M.;Liau J.-Y.;Tsai J.-H.;Hsu H.-H.;Ching-Yao Yang; Lee J.-C.; Jeng Y.-M.; Liau J.-Y.; Tsai J.-H.; Hsu H.-H.; CHING-YAO YANG |
| 臺大學術典藏 |
2020-02-20T02:56:56Z |
The diagnostic utility of PAX8 for neuroendocrine tumors: An immunohistochemical reappraisal
|
Liau J.-Y.; Tsai J.-H.; Jeng Y.-M.; Kuo K.-T.; Huang H.-Y.; Liang C.-W.; CHING-YAO YANG |